Western University

Scholarship@Western
Paediatrics Publications

Paediatrics Department

1-1-2017

Frizzled gene expression and negative regulation of canonical
WNT-β-catenin
WNT- -catenin signaling in mouse F9 teratocarcinoma cells
Gregory Golenia
Western University

Mohamed I. Gatie
Western University

Gregory M. Kelly
Children's Health Research Institute, London, ON, gkelly@uwo.ca

Follow this and additional works at: https://ir.lib.uwo.ca/paedpub

Citation of this paper:
Golenia, Gregory; Gatie, Mohamed I.; and Kelly, Gregory M., "Frizzled gene expression and negative
regulation of canonical WNT-β-catenin signaling in mouse F9 teratocarcinoma cells" (2017). Paediatrics
Publications. 1952.
https://ir.lib.uwo.ca/paedpub/1952

Biochemistry and Cell Biology

Frizzled Gene Expression and Negative Regulation of
Canonical WNT-ββ
β -catenin Signaling in Mouse F9
Teratocarcinoma Cells

Journal:
Manuscript ID
Manuscript Type:
Date Submitted by the Author:
Complete List of Authors:

Biochemistry and Cell Biology
bcb-2016-0150
Article
11-Jul-2016

Keyword:

af

Dr

Golenia, Gregory; University of Western Ontario, Biology, Molecular
Genetics Unit
Gatie, Mohamed; University of Western Ontario, Biology, Molecular
Genetics Unit
Kelly, Gregory; University of Western Ontario, Biology, Molecular Genetics
Unit; Child Health Research Institute; Ontario Institute for Regenerative
Medicine
WNT, β-catenin, Mouse Embryo, Extraembryonic Endoderm, Dickkopf

t
https://mc06.manuscriptcentral.com/bcb-pubs

Page 1 of 29

Biochemistry and Cell Biology

Frizzled Gene Expression and Negative Regulation of Canonical
WNT-β-catenin Signaling in Mouse F9 Teratocarcinoma Cells

Gregory Golenia1, Mohamed I. Gatie1 and Gregory M. Kelly1,2,3*

Dr

1 Department of Biology, Molecular Genetics Unit, Western University, London, ON, Canada

af

N6A 5B7. 2. Child Health Research Institute, London, ON N6C 2V5, and 3. Ontario Institute for

t

Regenerative Medicine, Toronto, Ontario, Canada M5G 0A4.

Email: gkelly@uwo.ca

Keywords: WNT, ß-catenin, Mouse Embryo, Extraembryonic Endoderm, Dickkopf

https://mc06.manuscriptcentral.com/bcb-pubs

Biochemistry and Cell Biology

Page 2 of 29

Abstract: Mouse F9 cells differentiate into primitive endoderm (PrE) following the activation of
the canonical WNT/β-catenin pathway. The upregulation of Wnt6 and activation of β-cateninTCF/LEF-dependent transcription is known to accompany differentiation, but the Frizzled (FZD)
receptor responsible for transducing the WNT6 signal is not known. Eight of the ten Fzd genes
were found to be expressed in F9 cells, with Fzd7 being the most highly expressed, and chosen
for further analysis. To alter steady-state Fzd7 levels and test the effect this has on
differentiation, siRNA and overexpression approaches were used to knockdown and ectopically
express the Fzd7 message, respectively. siRNA knock down of Fzd7 resulted in reduced DAB2
levels, and the overexpression activated a TCF-LEF reporter, but neither approach affected
differentiation. Our focus turned to how canonical WNT6 signaling was attenuated to allow PrE
cells to form PE. Dkk1, encoding a WNT antagonist, was examined and results showed that its
expression increased in F9 cells treated with RA or overexpressing Wnt6. F9 cells
overexpressing human DKK1 or treated with DKK1-conditioned medium and then treated with
RA failed to differentiate, indicating that a negative feedback loop involving WNT6 and DKK1
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attenuates canonical WNT/β-catenin signaling, thereby allowing PE cells to differentiate.
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Introduction
During mouse early embryogenesis the blastocyst consists of the trophectoderm, the
epiblast, and the primitive endoderm (PrE) (Rossant and Tam 2009). PrE differentiates into
parietal endoderm (PE) and visceral endoderm (VE), which develop into the parietal and visceral
yolk sacs, respectively (Boiani and Scholer 2005). PE formation occurs around implantation, and
although difficult to study in vivo, there are alternative in vitro models including the F9
teratocarcinoma cell line (Strickland et al. 1980). F9 cells treated with retinoic acid (RA)
undergo changes that mimic the formation of PrE (Strickland and Mahdavi 1978; Yang et al.
2011). Subsequent addition of db-cAMP induces PE, and if grown in suspension culture, PrE
cells differentiate into VE (LaMonica et al. 2009; Verheijen et al. 1999). One of several
pathways activated by RA involves canonical WNT/β-catenin signaling (Krawetz and Kelly
2008; Liu et al. 2002).
WNTs are secreted glycoproteins that elicit numerous cellular responses in vertebrate and
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invertebrate animals. The nineteen mammalian WNTs that bind to one or more of the ten plasma
membrane spanning Frizzled (FZD) receptors signal through the canonical WNT/β-catenin,
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and/or the non-canonical WNT/Ca2+ or planar cell polarity (PCP) pathways (Logan and Nusse
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2004; Moon 2005). The effects of pathway activation are pleiotropic and include stimulation of
cell proliferation, cell motility and control of cell fate and differentiation (Logan and Nusse
2004). In F9 cells, RA treatment up-regulates Wnt6, and the subsequent activation of the
canonical pathway allows for the interaction of β-catenin with the T-cell-factor-lymphoid
enhancer factor (TCF-LEF) family of transcription factors. This interaction promotes the
expression of genes necessary for PrE induction (Krawetz and Kelly 2008), and as found here,
genes involved in attenuating the WNT6 signal.
F9 cells require the activation of canonical WNT signaling to induce cells to form PrE,
and non-canonical WNT signaling pathways to complete differentiation (Krawetz and Kelly
2008; LaMonica et al. 2009). Therefore, either a WNT and/or a receptor that has the potential to
activate both of these WNT signaling pathways would be ideally suited to induce the
differentiation of F9 cells into PE. Both FZD7 and WNT6 mediate canonical and non-canonical
signaling in several cell types, and there is a link between the two in embryos (Beaton et al.
2016; King et al. 2012; Linker et al. 2005; Schmidt et al. 2007; Zhang et al. 2013). Based on this
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evidence, we postulated that FZD7 was the WNT6 receptor that transduces the signal to induce
F9 cells to differentiate towards PrE.
In addition to WNT6 acting through a FZD receptor to regulate genes required for the
differentiation to PrE, mechanisms are in place to attenuate the canonical WNT signal for these
cells to differentiate into PE and VE (LaMonica et al. 2009; Schlupf and Steinbeisser 2014;
Shibamoto et al. 2004). There is evidence that F9 cells express intracellular and extracellular
inhibitors of WNT signaling during differentiation (Shibamoto et al. 2004; Zhuang et al. 2003).
Dickkopf (DKK) proteins are extracellular antagonists of WNT signaling (Kawano and Kypta
2003), and the expression of Dkk1 in F9 cells was reported to be RA-induced in VE cells
(Shibamoto et al. 2004).
Our studies have shown that eight of ten Fzd genes were expressed in F9 cells and Fzd7
is the most highly expressed. Genetic manipulations of Fzd7 were not sufficient to affect the
induction of F9 cells into PrE. Nevertheless, we have identified a negative feedback loop
initiated by canonical WNT6 signaling involving the WNT antagonist, DKK1, that permit cells

Dr

to continue their differentiation from PrE to PE.

af

Materials and methods

t

Cell culture, reverse transfection, and chemical treatments
Mouse F9 teratocarcinoma cells (ATCC) were cultured in Dulbecco’s Modified Eagle
Medium (DMEM) (Gibco) supplemented with 1% penicillin-streptomycin (P/S) (Gibco) and
10% fetal bovine serum (FBS) (Gibco) and incubated at 37°C and 5% CO2. Cells were cultured
in 35 mm plates for transfection or 60 mm plates (Nunc Thermoscientific or Sarstedt) for protein
and/or RNA isolation. Cells were transfected with empty vector, pcDNA3.1-Fzd7 (B. Cadesky,
Western University), pcDNA3.1-Wnt6, pcDNA3.1-Myc-DKK1 (Dr. Y. Li, Southern Research
Institute, Birmingham, AL), pBARL (Dr. S. Angers, University of Toronto) and pRL-TK (Dr. R.
Dekoter, Western University), using Lipofectamine 2000 (Life Technologies).
For the Fzd7 knockdown, three 27-mer antisense RNA sequences (Origene) were pooled
together at 10nM each. Approximately 2.5 x 105 cells were added to 2 mL DMEM with serum
and antibiotics and seeded directly into 35 mm dishes containing the Opti-MEM transfection
mix. Medium was replaced after 6h and approximately 1 x 105 cells were plated into 60 mm
dishes after 24h and selected for antibiotic resistance with 1.75 mg/mL G418 sulfate (Sigma).
4
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Cells transfected with pcDNA3.1-Myc-DKK1or treated with MYC-DKK1-conditioned medium
were treated with DMSO or 5 x 10-8 M RA for 4 days. For all other experiments, cells were
treated with DMSO or 10-7 M RA for 3 or 4 days.

Reverse-transcription PCR and quantitative reverse-transcription PCR
Total RNA was isolated using the RNeasy Mini Kit (Qiagen) and used as a template for
first-strand cDNA synthesis, using the High Capacity cDNA Reverse Transcription kit (Applied
Biosystems). RNA was isolated following treatment of F9 cells with DMSO, RA (1, 2, 3, and 4
days post-treatment) or RA and db-cAMP (1mM), and for RT-PCR and qRT-PCR with Fzd
primers, DNase digestion was performed using the RNase-Free DNase kit (Qiagen). Purity and
concentration of RNA was analyzed using a NanoDrop2000C Spectrophotometer (Thermo
Scientific). PCR reactions were analyzed on 1% agarose gels containing RedSafe Nucleic Acid
Stain (iNtRON Biotechnology) and amplicons were visualized using a FluorChem 8900 Gel Doc
System (Alpha Innotech). All reactions were performed using the following thermo-cycling

Dr

conditions for 35-40 cycles: 94°C for 30s, the primer-specific annealing temperature for 30s and
72°C extension for 30s. All amplicons were sequenced (Robarts Research Institute, Western

af

University) and aligned to annotated sequences using the NCBI Basic Local Alignment Search

t

Tool (BLAST) to confirm their identity. Primers sequences and annealing temperatures are listed
in the Supplemental Information.
For qRT-PCR analysis, total RNA was isolated and reverse-transcribed into first-strand
cDNA as described above. For Fzd expression analysis, qRT-PCR was performed using the
Rotor-Gene 3000 (Corbett Research) and Power SYBR Green Master Mix (Applied
Biosystems). For all other qRT-PCR reactions, the CFX Connect Real-Time PCR Detection
System (Bio-Rad) was used with the SensiFAST SYBR No-ROX Kit (Bioline). Each qRT-PCR
reaction contained 10µL of Power SYBR Green Master Mix or SensiFAST SYBR, 500nM of
each primer, and 1µL of cDNA template. Amplification plots were analyzed using the RotorGene or CFX Manager software. Gene expression was quantified using the comparative cycle
threshold (Ct) method and displayed as gene expression relative to the constitutively active L14
gene (2-ΔCt) or as fold-change (2-ΔΔCt) relative to DMSO or empty vector control.
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Immunoblot analysis
Protein lysates were prepared in RIPA buffer containing 150mM sodium chloride, 1%
NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50mM Tris-HCl and 1x Halt Protease inhibitor
cocktail (Thermo Scientific). Protein concentrations were quantified using the Detergent
Compatible protein assay (Bio-Rad) and Modulus II Microplate Multimode Reader (Turner
Biosystems). Approximately 20µg of protein were separated on 10% denaturing polyacrylamide
gels for 2.5h at 100V. Following electrophoresis, the proteins were electrophoretically
transferred to polyvinylidene fluoride membranes (Pall Corporation) overnight at 4°C and 20V
in Tris-glycine transfer buffer containing 20% methanol. The membranes were blocked in Trisbuffered saline containing 0.1% Tween 20 (TBS-T) and 5% skim milk for 1h at room
temperature. Membranes were probed overnight at 4°C with the following primary antibodies
diluted in 5% bovine serum albumin (BSA) containing TBS-T: TROMA-1 (1:5; 55kDa,
Developmental Studies Hybridoma Bank), DAB2 (1:10000; 96kDa, BD Transduction
Laboratories), β-actin (1:5000; 47kDa, Santa Cruz) and c-MYC (9E10) (1:50, approximately 39

Dr

kDa, Santa Cruz). Membranes were washed in TBS-T (three washes for five minutes each) and
then probed with either HRP-conjugated goat anti-rat or anti-mouse secondary antibody in 5%

af

skim milk in TBS-T for 2h at room temperature. Following three additional five minute washes

t

with TBS-T, signals were detected using the Supersignal West Pico Chemiluminescent Detection
Kit (Pierce), then captured on a Molecular Imager Gel Doc XR System (Bio-Rad) and imaged
with Quantity One Software. Densitometry analysis was performed using ImageJ software.

TCF/LEF reporter assay
Cells transfected with pBARL and then treated with DMSO or 10-7 M RA, or cotransfected with pBARL and pcDNA3.1-EV (empty vector) or pcDNA3.1-Fzd7 in equal amounts,
were collected 48h post-treatment or post-transfection. Cells were also co-transfected with pRLTK (Renilla luciferase) to normalize luciferase levels. Lysates were collected by shaking cells in
1 X Passive Lysis Buffer (Promega) for 15min at room temperature. Luciferase activity was
quantified using the Dual Luciferase Assay Reporter System (Promega) and the Modulus II
Multimode Microplate Reader (Promega). Firefly luciferase values were normalized to Renilla
luciferase values.
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MYC-DKK1 conditioned medium
HEK-293 cells were grown to 90% confluence in 60 mm culture dishes and maintained in
DMEM with 10% FBS and 1% P/S. Cells were transfected using 10µL Lipofectamine 2000 with
4µg pcDNA3.1-EV (empty vector) or pcDNA3.1-Myc-DKK1. Medium was replaced with
complete DMEM after 6h and replaced again with serum-free medium containing 1% P/S after
24h. The medium was collected after 48h and centrifuged at 10,000 x g for 10min at 4°C to
pellet cellular debris. The supernatant was filter sterilized using 0.2 µm Acrodisc Syringe Filters
(Pall Corporation) and concentrated using Amicon Ultra-4 Centrifugal Filter Units (10,000
nominal molecular weight limit-EMD Millipore). Approximately 1.2x104 F9 cells were seeded in
12-well plates and co-treated with 5x10-8 M RA and 10µL of media concentrate from pcDNA3.1EV or pcDNA3.1-Myc-DKK1-transfected cells. Cells were supplemented with 10µL of
concentrated medium every day for a total of 4 days. For immunoblot analysis of concentrated
conditioned medium, 5, 10 or 15µL of medium from pcDNA3.1-EV or pcDNA3.1-Myc-DKK1transfected cells were resolved by electrophoresis on 10% denaturing polyacrylamide gels,

Dr

transferred to PVDF membranes and probed using the 9E10 antibody (Santa Cruz).

af

Statistical analysis

t

Densitometric analyses of immunoblots, qRT-PCR data, and luciferase assay data were
compiled from three independent biological replicates. Comparisons of data between the control
and treated, or transfected groups were performed using a one-way ANOVA and Tukey’s honest
significant difference (HSD) post-hoc test or a Student’s t-test (SPSS Statistics for Windows
Version 19.0, IBM Corp. Released 2010, Armonk, NY). One-way ANOVA followed by Tukey’s
HSD test was used for the statistical analysis of the luciferase assay data, Dkk1 and Dab2 qRTPCR data, and densitometry data of the TROMA-1 and DAB2 immunoblots from the Fzd7
knockdown and overexpression experiments. Student’s t-test was used for statistical analysis of
all other data. P-values were one-sided and considered statistically significant at the 0.05 level.
Statistical data are presented as the mean ± S.E.

Results and Discussion
WNT signaling pathways, which are evolutionarily conserved in Metazoans, play
instrumental roles in a number of events including cell migration, cell fate determination,
7
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organogenesis, stem cell pluripotency, tissue homeostasis, and when dysregulated, fibrosis and
carcinogenesis. The result of a WNT ligand binding to its cognate FZD receptor is the initiation
of one or several intracellular signaling cascades, which include the canonical WNT/β-catenindependent pathway and the non-canonical, β-catenin-independent planar cell polarity (PCP) and
WNT/Ca2+ pathways. There are ten different FZD receptors and nineteen WNT ligands that have
been identified in mammals, allowing for a remarkable number of receptor-ligand combinations
that complicates the understanding of how one particular WNT pathway is activated
preferentially over another (Moon 2005). This preferential selectivity of a signaling branch is
thought to depend on several factors such as the intrinsic properties of WNTs and FZDs
themselves, as well as presence of the receptors and co-receptors in a cell-dependent context
(Dijksterhuis et al. 2014).
In this study F9 cells were used to investigate how the canonical WNT/β-catenin
signaling pathway, and specifically the role of the FZD receptors, specify relatively naïve cells to

Dr

not only adopt the PrE fate, but how the signal is attenuated to permit these cells to complete
their differentiation to PE. F9 cells differentiate into PrE when treated with RA, and this is

af

accompanied by the upregulation of Wnt6 and activation of the canonical WNT/β-catenin
pathway (Krawetz and Kelly 2008). Wnt6 is upregulated by the transcription factors GATA6 and

t

FOXA2, which bind to and activate the Wnt6 promoter in F9 cells (Hwang and Kelly 2012).
Although the involvement for WNT6 in RA induced differentiation is clear, the receptor(s)
responsible for binding WNT6 and transducing the differentiation signal, and then for its
attenuation is/are unknown.

Fzd expression in F9 and PrE cells
It was reported previously that all ten members of the Fzd family are expressed in F9
cells (Okoye et al. 2008). In light of the fact that this previous study also reported that eighteen
of the nineteen Wnt genes were also expressed in F9 cells, despite our ability to only detect Wnt6
(Krawetz and Kelly 2008), it was decided to re-evaluate the entire Fzd expression profile. F9
cells were treated with RA to induce PrE and total RNA was isolated after 3 days and reversetranscribed into cDNA for end point PCR using primers for Fzd1 through Fzd10, except Fzd7
(described later) (Supplementary data). Results showed amplicons for Fzd1, 2, 4, 5, 6, 8 and 10
members in undifferentiated and RA-treated F9 cells (Fig. 1A). The expression of Fzd3 and Fzd9
8
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was not detected even after 40 cycles of PCR or when the annealing temperature was altered
(data not shown). To confirm that Fzd3 and Fzd9 were not expressed in F9 cells, mouse tissues
known to express these genes were isolated and used in a PCR analysis with the same primers
and conditions used in the F9 analysis. Total RNA was collected from mouse dermis and
hippocampus, known to express Fzd3 and Fzd9, respectively, and reverse-transcribed into cDNA
for end point PCR with Fzd3 and Fzd9 primers (Fig. 1B). Fzd3 and Fzd9 were expressed in the
mouse dermis and hippocampus, respectively, but not in cDNAs from F9 cells. Sequence
analysis confirmed the identity of the amplicons as Fzd3 and Fzd9 (data not shown).
Detecting the expression of these Fzd genes in F9 cells prompted further analysis to
determine by quantitative means if the genes were RA-responsive. Since the Fzd amplicons
shown in Fig. 1 were detected using 40 cycles of PCR, subtle differences in expression of each
gene between the undifferentiated and RA-treated cells would be difficult to identify. To address
this, F9 cells were treated with DMSO or RA for 3 days and total RNA was isolated and reversetranscribed into cDNA for qRT-PCR. Results showed that Fzd1, 4, and 8 were significantly

Dr

upregulated by RA treatment, showing a 9.82, 4.86, and 3.69-fold increase in expression relative
to control, respectively (Fig. 1C). Fzd2 and Fzd6 showed a slight increase in expression after

af

exposure to RA, but changes for either were not statistically significant (Fig. 1C). The expression

t

of Fzd5 and Fzd10 was lower following RA treatment, showing a 0.52 and 0.61 fold-decrease
relative to control, respectively, however this decrease in expression was again not statistically
significant (Fig. 1C). It appears that while Fzd1, 4 and 8 genes were RA-responsive, Fzd 2, 5, 6,
and 10 were not. Furthermore, it is interesting to note that while Fzd1 showed the greatest overall
increase in this group after three days of RA treatment, Fzd7 was the most abundantly expressed
of the Fzd family (Fig. 2).

Frizzled7 expression in undifferentiated F9 and RA-induced PrE cells
The ability of F9 cells to differentiate into PrE when treated with RA and to PE when
exposed subsequently to RA and db-cAMP is well known (Strickland and Mahdavi 1978;
Strickland et al. 1980). As noted above, RA-induced differentiation is accompanied by an
increase in Wnt6 expression, and WNT6 by itself induces PrE (Krawetz and Kelly 2008).
Although a receptor for WNT6 in F9 cells has not been identified, FZD7 is a candidate as there
have been several reports linking it and WNT6 (Beaton et al. 2016; Linker et al. 2005; Schmidt
9
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et al. 2004; Schubert et al. 2002). Furthermore, WNT/β-catenin signaling activates TCF/LEF
activity in F9 cells (Hwang and Kelly 2012; Sandieson et al. 2014) and there is evidence for
TCF/LEF consensus binding sequences in several Fzd promoters including Fzd7 (Kolben et al.
2012). FZD7 is one of the most studied family member, and is known to bind to several WNT
ligands to transduce the signal to a number of different pathways (Phesse et al. 2016). To analyze
the expression of Fzd7, total RNA was collected from F9 cells treated with RA, and then reversetranscribed into first-strand cDNA for qRT-PCR. The expression profile of Gata6 was first
examined to ensure cells had responded to RA by day 4 (Fig. 2A). Gata6 is a RA responsive
gene up-regulated when cells differentiate into PrE (Hwang and Kelly 2012), and qRT-PCR
analysis showed its expression compared to that in DMSO-treated controls was significantly
higher in RA-treated cells (Fig. 2A). Having established that cells had differentiated following
RA treatment, the cDNAs collected as described above were analyzed by qRT-PCR and Fzd7specific primers. Fzd7 was, however, first examined using end point PCR and results showed the
presence of an amplicon in the days 1-4 RA treatments and the DMSO-treated controls (data not

Dr

shown). These amplicons were sequenced and all were found to be identical to the Fzd7
sequence appearing in the NCBI Nucleotide database. qRT- PCR using Fzd7-specific primers

af

showed that there was no significant increase in Fzd7 mRNA abundance due to RA treatment on

t

day 3 relative to controls, but the differences were significant by day 4 (Fig. 2B).

Overexpression of Fzd7 activates canonical WNT/β-catenin signaling in F9 cells, but is not
sufficient to induce PrE
Up-regulation of Fzd7 by RA was originally thought to be an attribute that would
contribute to PrE differentiation, but the fact that WNT6-conditioned media differentiates F9
cells to PrE indicated a FZD receptor must be available to tranduce the signal even in the
absence of RA (Krawetz and Kelly 2008). Thus, the requirement of Fzd genes to be RA
responsive may be unnecessary. Nevertheless, given its relatively high level of expression in F9
cells, and the reported link between it and WNT6, Fzd7 was selected for further investigation.
There is also precedence for FZD7 as the candidate receptor involved in PrE differentiation,
because like WNT6 (Linker et al. 2005; Schmidt et al. 2007), it is involved in the activation of
both canonical and non-canonical WNT signaling pathways (Phesse et al. 2016; Zhang et al.
2013). Furthermore, both pathways are necessary for PrE and PE formation, respectively, in F9
10
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cells (LaMonica et al. 2009; Liu et al. 2002). Fzd7 was the most abundantly expressed Fzd in F9
cells, and this is in agreement with the expression profile in human ESCs (Fernandez et al.
2014). Likewise, in NT2/D1 embryonal carcinoma cells several Wnt and Fzd genes, including
Fzd7 are up-regulated in response to RA (Snow et al. 2009). The overexpression of Fzd7 has
been reported in many types of human cancers, notably, colorectal cancer, hepatocellular
carcinoma, and triple-negative breast cancer (Merle et al. 2004; Yang et al. 2011). Previous
studies have reported that WNT pathway activation does not occur following the ovexpression of
Fzd (Yang et al. 2011), but there is contradictory evidence showing that in the absence of the
WNT ligand FZD overexpression can activate the WNT pathway (Sheldahl et al. 1999;
Umbhauer et al. 2000; Veeman et al. 2003). If overexpression of Fzd7 in F9 cells is sufficient to
activate canonical WNT signaling required for PrE formation, then increased β-catenin/TCFLEF transcriptional activity and downstream targets such as DAB2 should be detected. To test
this, F9 cells were transfected with Fzd7 or pcDNA3.1 and selected with G418 for 5 days, or
treated with RA or DMSO as positive and negative controls for differentiation, respectively.

Dr

Total RNA was collected, reverse-transcribed into cDNA, and used for qRT-PCR with Fzd7
primers to verify that Fzd7 was overexpressed. qRT-PCR results showed that Fzd7 mRNA was

af

expressed greater than 50-fold higher in Fzd7-transfected cells relative to empty vector control

t

(Fig. 3A). Confident that Fzd7-transfected F9 cells showed increased Fzd7 expression, F9 cells
were analyzed for β-catenin/TCF-LEF-dependent transcription using a Dual-Luciferase reporter
assay system. Cells were co-transfected with pBARL (β-catenin-activated reporter luciferase) to
detect activation of TCF/LEF-dependent transcription and pRL-TK (Renilla luciferase) plasmids,
and either Fzd7 or pcDNA3.1-empty vector (EV). Cells co-transfected with pBARL and pRL-TK
and treated with RA or DMSO were used as positive and negative controls, respectively. pRL-TK
was used to normalize luciferase values. Relative to the DMSO-treated cells, results indicated
that cells treated with RA or transfected with Fzd7 showed a significant increase in luciferase
activity (4.32 and 3.06-fold higher luciferase activity, respectively) (Fig. 3B). DMSO and EVtransfected cells both exhibited approximately equal levels of luciferase activity. Thus, the
results indicated that overexpressing Fzd7 was sufficient for activation of β-catenin/TCF-LEFdependent transcription in F9 cells. Surprisingly, however, DAB2 levels were barely detectable
in Fzd7-transfected F9 cells, despite the increase in luciferase activity (Fig. 3C). Densitometric
analysis further showed that DAB2 levels were not signficantly different in undifferentiated EV11
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tranfected and Fzd7-transfected F9 cells (Fig. 3D). Furthermore, TROMA-1 signals, which
would denote cytokeratin 8 in differentiated cells (Brulet et al. 1980) were only seen in the RApositive controls (Fig. 3E). Although there may be several reasons to explain these results, it is
likely that despite the reporter assay being sensitive enough to indicate activation, the
overexpression by itself was not adequate for the requisite activation of endogenous genes
needed to induce these naïve cells. However, without demonstrating increased FZD7 protein
expression in transfected cells, alternative explanations for the discrepancy between increased
reporter activity in the absence of differentiation must also be considered.

Fzd7 knockdown does not inhibit RA-induced primitive endoderm differentiation
Knockdown of Fzd7 in many human cancer cell types decreases β-catenin/TCF-LEF
activity, invasion, and migration (Ueno et al. 2009; Yang et al. 2011). If this is true for F9 cells,
and FZD7 binds WNT6 to transduce a differentiation signal, then depleting cells of Fzd7 is

Dr

expected to prevent PrE differentiation. To address if F9 cells under reduced levels of Fzd7 could
be induced to differentiate into PrE, cells were transfected with short interfering RNA (siRNA)

af

to knock down endogenous Fzd7 transcripts or transfected with a non-targeting control siRNA.
qRT-PCR was used to confirm that Fzd7 mRNA levels were reduced in Fzd7 siRNA-transfected

t

cells relative to the non-targeting control siRNA-transfected cells (Fig. 4A). Given these results
and confident that this approach had reduced Fzd7 expression, siRNA-transfected cells were
treated with RA and protein lysates were harvested for immunoblot analysis using DAB2 and
TROMA-1 antibodies. Immunoblot and densitometric analyses showed that DAB2 levels were
significantly less in Fzd7 siRNAs-transfected F9 cells when compared to non-targeting control
cells treated with RA (Figs. 4B and 4C, respectively). Cytokeratin8 positive intermediate
filaments, however, were present at approximately equal amounts in all RA-treated cells,
including those transfected with Fzd7 siRNAs or non-targeting control siRNA (Fig. 4D).
Densitometric analysis further showed that TROMA-1 levels were not significantly different due
to Fzd7 siRNA transfection (Fig. 4E). These results indicated that reducing the message
encoding the FZD7 receptor using an siRNA approach reduced DAB2 signal, but did not have a
detrimental effect on the appearance of TROMA-1 intermediate filaments indicative of PrE
differentiation. Thus, despite the knockdown of Fzd7, which should have reduced the overall

12

https://mc06.manuscriptcentral.com/bcb-pubs

Page 13 of 29

Biochemistry and Cell Biology

amount of the protein, the remaining may be still sufficient to transduce the WNT6 signal. Since
FZD7 protein levels were not assessed in this study due to inherent specificity problems
associated with commercially-available antibodies, others scenarios may exist. For instance,
these results would not support the idea that FZD7 is the receptor necessary for PrE
differentiation, but given the functional redundacy issue reported for FZD receptors (Huang and
Klein 2004), however, it is also possible that reduced levels of the FZD7 receptor were
compensated by one or more FZDs, encoded by mRNAs already present in F9 cells (see above).
Without reliable antibodies to the FZD family or the ability to knock-down the expression of all
Fzd genes, and then rescue each on an individual basis, this would be difficult to test. Homology
analysis of FZD1, 2 and 7 indicates that they share approximately 75% sequence identity, and
even though this number falls between FZDs in different clusters, there is still a significant
amount of overlap (Fredriksson et al. 2003). For example, FZD5 and FZD7, which are in
different clusters, are functionally redundant for canonical WNT/β-catenin signaling in cell
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culture, as ectopic expression of Fzd5 in human mesenchymal stem cells (hMSCs) harboring a
Fzd7 knockdown can rescue TCF/LEF luciferase reporter activity. Similarly, ectopic expression

af

of Fzd7 can rescue the same reporter activity in Fzd5 knockdown hMSCs (Kolben et al. 2012).
Given this information, an alternative strategy would be to knockdown more than one FZD
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receptor, and if even technically plausible, the possibility remains that another Fzd could be upregulated in response. Unfortunately, and despite the fact that there appear to be more reports
detailing the use of antibodies to inhibit FZDs (Blagodatski et al. 2014), and specifically FZD7
(Ueno et al. 2009; Ueno et al. 2013), and in light of the paucity of direct evidence in assigning
individual FZDs to specific WNTs (Dijksterhuis et al. 2015; Dijksterhuis et al. 2014), testing
each scenario would be a laborious process.
Although the knockdown of Fzd7 in F9 cells did not attenuate RA-induced PrE
differentiation, given that Wnt6 expression is down-regulated when PrE cells are treated with dbcAMP (Krawetz and Kelly 2008), and knowing mechanisms are in place to temper canonical
WNT signaling during differentiation (Schlupf and Steinbeisser 2014; Shibamoto et al. 2004) we
investigated how canonical WNT6 signaling might be involved in this attenuation process.
Dkk1 mRNA expression is induced by RA treatment and Wnt6 overexpression
A microarray profiling study using F9 cells reported on two RA-target genes Dab2 and
sFRP5, which encode inhibitors of WNT signaling (Zhuang et al. 2003). Interestingly, F9 cells
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induced to differentiate into VE are not responsive to WNT ligands, pointing to a blockade in
WNT signaling that accompanies differentiation (Shibamoto et al. 2004). Another defined
mechanism involves IGF, which induces Axin2 and stabilizes AXIN1 (Schlupf and Steinbeisser
2014). Thus, there are several mechanisms in place, but other inhibitors of WNT signaling may
also be induced in response to activated WNT6 signaling. Candidates that would serve in this
capacity to antagonize WNT-β-catenin signaling are members of the DKK family, which are upregulated in F9 cells induced to form VE (Shibamoto et al. 2004). Furthermore, DKK1/Dkk1 is a
direct target gene of WNT-β-catenin signaling as several TCF-binding element consensus sites
have been identified within a highly conserved region 1kb upstream of the transcription start site
in the human and mouse promoters (Niehrs 2006; Niida et al. 2004). Other evidence comes from
studies showing that DKK1 acts as a secreted antagonist specifically inhibiting canonical WNT
signaling when it binds to the LDL receptor-related protein 5/6 (LRP5/6) co-receptor, which
blocks the LRP5/6-WNT interaction that is obligatory for canonical pathway activation (He et al.
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2004; Liu et al. 2002; Pinson et al. 2000). Therefore, to test if Dkk1 was up-regulated in PrE
cells, F9 cells were treated with 10-7 M RA for 1-4 days, or DMSO for 4 days and total RNA was
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collected and reverse-transcribed into cDNA for qRT-PCR analysis (Fig. 5). Results indicated
that Dkk1 expression increased by 118 and 611-fold in cells treated with RA for 3 and 4 days,

t

respectively, compared to DMSO control cells (Fig. 5A). Thus, the Dkk1 gene like Wnt6 was
RA-responsive, but whether or not it is a WNT6 target gene required further analysis.
F9 cells were transfected with Wnt6 or pcDNA3.1-EV, and then treated with G418 for 4
days, and total RNA was collected and reverse-transcribed into cDNA to be used as template for
end point and qRT-PCR analyses. To confirm that Wnt6 was being overexpressed, cDNAs were
used for end point PCR with primers for Wnt6. Results showed the presence of a Wnt6 amplicon
in cells transfected with pcDNA3.1-Wnt6 (Fig. 5B). Correspondingly, a Wnt6 amplicon was not
detected in cDNA from empty vector-transfected cells, but the presence of an L14 amplicon
indicated that cDNA was available for amplification. Confident that Wnt6 was being
overexpressed, Dkk1 expression was examined and results showed a 2.92-fold increase in Dkk1
expression in cells transfected with Wnt6 compared to the empty vector-transfected controls (Fig.
5C).
DKK1/Dkk1 is reportedly regulated by the β-catenin/TCF/LEF transcriptional complex in
several cell lines, and there are four TCF/LEF DNA binding motifs located within the human
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(DKK1) and mouse Dkk1 promoters (Logan and Nusse 2004). Since Dkk1 expression was greatly
increased in the presence of RA, and only slightly increased due to Wnt6 overexpression,
subsequent analysis focussed on searching the mouse Dkk1 promoter region for conserved
Retinoic Acid Response Elements (RARE) binding sites, the presence of which might explain
the greater than 600-fold upregulation of Dkk1 by RA. The Ensembl Genome Browser
Regulatory Build was used to identify putative regulatory regions upstream of the Dkk1
transcription start site, and a 961bp sequence was predicted as the Dkk1 promoter region. This
sequence was used to identify putative RARE consensus DNA motifs and two conserved RARE
nucleotide sequences were found within this region, spaced 9bp apart (data not shown). These in
silico results would suggest that in addition to Dkk1 as being a WNT6 target gene, the potential
exists that the regulation of the Dkk1 is also under the control of RAR-RXR homo/heterodimers.
ChIP analysis should provide more insight into the Dkk1 regulation by WNT-β-catenin and RA
signaling, and these studies are currently underway.
Since Dkk1 expression was up-regulated in response to RA and Wnt6 overexpression, and

Dr

overwhelming evidence indicates that DKK1 is a WNT antagonist, then the ectopic expression of
Dkk1 should block PrE differentiation. To test this, F9 cells were transfected with a Myc-tagged
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human DKK1 (Myc-DKK1) construct and selected with G418, then treated with RA for 4 days to

t

induce PrE. Protein lysates were collected and processed for immunoblot analysis with the
TROMA-1 antibody to determine if cells had been blocked from differentiating into PrE.
Immunoblot analysis showed that cytokeratin 8 was expressed in the positive controls treated
with RA or transfected with empty vector and treated with RA (Fig. 6A). Cytokeratin 8 levels,
however, appeared to be reduced in cells transfected with the Myc-DKK1 construct and treated
with RA (Fig. 6A). Densitometric analysis confirmed this significant decrease in TROMA-1
levels in cells transfected with Myc-DKK1 and treated with RA compared to cells transfected
with empty vector and treated with RA (Fig. 6B). The reduction in the TROMA-1 signal in cells
transfected with empty vector and treated with RA compared to cells treated with RA alone
would indicate that the transfection had affected differentiation (Fig. 6A). Although this should
not have occurred, all subsequent experiments were conducted using transfected-positive
(pcDNA3.1 + RA) and negative controls (pcDNA3.1 + DMSO). Experiments were repeated to
examine another marker of PrE differentiation and intracellular WNT antagonist, encoded by
Dab2 (Cho et al. 1999; Zhuang et al. 2003), which when translated inhibits WNT/β-catenin
15
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signaling by binding LRP6 and promoting its internalization, as well as by interacting with and
stabilizing AXIN, preventing the destruction complex disassembly (Jiang et al. 2008; Pataki et
al. 2015). If Myc-DKK1 ectopic expression negatively affected PrE differentiation, then it was
expected that Dab2 expression would be less than the controls. Total RNA was collected and
reverse-transcribed into cDNA and used for qRT-PCR analysis with Dab2 primers. Results
showed that relative to controls, Dab2 was upregulated more than 140-fold in empty vectortransfected and RA-treated cells, and by nearly 120-fold in cells transfected with Myc-DKK1 and
treated with RA (Fig. 6C). The difference was significant, and indicated that ectopically
expressed Myc-DKK1 in undifferentiated F9 cells reduced their ability to differentiate into PrE
when treated with RA.
The results from the overexpression of Myc-DKK1 indicated that ectopically expressing a
construct encoding a secreted antagonist of canonical WNT/β-catenin signaling in
undifferentiated F9 cells attenuated the ability of RA to induce the PrE phenotype. To
corroborate this data, conditioned medium (CM) from HEK-293 cells expressing Myc-DKK1

Dr

was applied to F9 cells prior to being treated with RA. Briefly, HEK-293 cells were transfected
with pcDNA3.1 or Myc-DKK1, and media was collected after 48 hours, filter sterilized, and

af

concentrated. HEK-293 protein lysates were also collected for immunoblot analysis with the

t

anti-c-MYC antibody (9E10) to confirm that the cells were translating the Myc-DKK1
transcripts. A signal at approximately 39kD corresponding to the molecular mass of MYCDKK1 was detected in HEK-293 cells transfected with the Myc-DKK1 construct, but not in cells
transfected with the empty vector (Fig. 7A). To confirm that the HEK-293 cells were secreting
the protein, the CM generated from these cells was concentrated and used for immunoblot
analysis. If the MYC-DKK1 protein was being translated and secreted by the cells, then the 9E10
antibody should recognize the MYC-epitope both in cell lysates and in the CM. The concentrated
CM was used for immunoblot analysis and a 39kD signal was detected in the medium from cells
transfected with Myc-DKK1, but not the empty vector (data not shown). Having evidence that
MYC-DKK1 was present in the CM, it was applied to F9 cells in the presence of DMSO or RA
to determine if it would mimic the effect of ectopically expressing Myc-DKK1 on differentiation.
Protein lysates were collected for immunoblot analysis and results showed a TROMA-1 signal
present in cells treated with the empty vector-CM and RA, but absent in cells treated with this
CM and DMSO. Thus, the CM did not contain factors that induced differentiation on its own
16
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(Fig. 7B). A TROMA-1 signal was present in cells treated with MYC-DKK1 CM and treated
with RA, however, its intensity appeared to be reduced compared to that seen in cells treated
with the empty vector-CM and RA (Fig. 7B). Densitometric analysis confirmed that the
reduction of TROMA-1 seen in cells treated with MYC-DKK1 CM and RA was significant
compared to cells treated with the empty vector-CM and RA (Fig. 7C). Taken together, these
results indicated that the HEK-293 cells were a useful vehicle for the production and secretion of
the MYC-DKK1 protein, and more importantly applying this CM to F9 cells in the presence of
RA attenuated the ability of the latter to induce PrE. Thus, and as noted above, the blockade in
WNT sginaling required for cells to form VE (Shibamoto et al. 2004), occurs much earlier, at the
time when cells have completed their differentiation to PrE. Furthermore, these results
demonstrated that the Dkk1 gene was induced by RA treatment, and more importantly it is a
WNT6 target gene. This expression pattern of Dkk1 parallels that of another inhibitor of WNT
signaling, Dab2, suggesting that canonical WNT/β-catenin signaling is inhibited in PrE cells at
more than one level and is the result of a negative feedback loop initiated by WNT6.
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In conclusion, we have shown that eight of ten Fzd genes were expressed in
undifferentiated F9 cells and only three were RA-regulated (Fig. 1). Fzd7 is the most highly

af

expressed of the Fzd genes expresssed in F9 cells (Fig. 2), and is up-regulated by RA (Fig. 2B).

t

Although the overexpression of Fzd7 was sufficient to activate a WNT-β-catenin reporter, it was
not sufficient to increase DAB2 levels or induce PrE formation (Fig. 3). However, knocking
down Fzd7 transcripts attenuated DAB2 levels, but had no apparent effect on differentiation
(Fig. 4). Based on the data, we cannot definitely conclude that FZD7 is the bona fide WNT6
receptor, as the possibility exists that the knockdown was compensated by another FZD receptor
acting in a functionally redundant manner, and/or if the overexpression experiments were
ineffective in producing enough protein necesssary to induce differentiation. However, we have
identified a WNT6-responsive gene encoding a WNT antagonist, DKK1 (Fig. 5) known to
particate in the differentiation of extraembryonic endoderm (Shibamoto et al. 2004). In this
model, canonical WNT6 signaling in F9 cells is necessary and sufficient for PrE formation, and
in a feedforward manner the subsequent WNT-induced antagonism between the ligand and the
FZD receptor(s) by DKK1, is necessary, as others have reported (LaMonica et al. 2009; Schlupf
and Steinbeisser 2014), for extraembryonic endoderm differentiation to occur (Figs. 6 and 7).
Our model also predicts that although Wnt6 expression is down-regulated in PrE cells (Krawetz
17
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and Kelly 2008), canonical WNT signaling is eventually blocked in part following the translation
of mRNAs encoding antagonists like DAB2 (Zhuang et al. 2003) and DKK1 (this study). Since
DKK1 antagonizes canonical WNT signaling by binding the WNT LRP5/6 co-receptor (Pinson
et al. 2000), any remaining WNT6 would still be available to bind other FZDs and/or coreceptors to activate non-canonical, β-catenin independent WNT signaling required for
extraembryonic endoderm to form (Bikkavilli et al. 2008; LaMonica et al. 2009). There is
precedence for the ability of the same WNT to activate canonical β-catenin-dependent signaling
over the non-canonical pathways and vice versa depending on the presesence of specific cofactors and/or co-recptors (Beaton et al. 2016; Mikels and Nusse 2006; Schmidt et al. 2007;
Yamamoto et al. 2008). Thus, it is tempting to speculate that F9 cells also utilize a similar
mechanism that involves DKK1 and other inhibitors to help mediate a switch from canonical
WNT/β-catenin to non-canonical PCP signaling in order to facilitate the transition from PrE to
PE. This model is currently being investigated as it will help further the understanding of how
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Fig. 1 Fzd gene expression in F9 cells. Total RNA was collected from F9 cells treated with either RA or DMSO
for 3 days or from mouse dermis and hippocampus and used as template for RT-PCR. (A) Agarose gels
showing amplicons corresponding to the predicted size of each Fzd amplicon. (B) Fzd3 and Fzd9 amplicons
were detected in mouse dermal and hippocampal tissues, confirming the utility of the primers used in the F9
cell analysis. Data are representative of three independent experiments. (C) Fzd receptor expression
(excluding Fzd7) in response to RA treatment. qRT-PCR analysis was used to determine the gene expression
profile of Fzd receptors relative to the control gene L14 in response to RA. While Fzd1, 4 and 8 were
significantly upregulated by RA at 3 days (9.82, 4.86, and 3.69 fold up-regulation relative to DMSO control
cells, respectively; Supplementary data), Fzd2, 5, 6, and 10 did not change significantly. Asterisks denote
significant difference (p≤0.05). Data represent the mean and standard error of three independent
experiments. Fold changes in Fzd mRNA expression relative to DMSO are presented in the Supplementary
data.

https://mc06.manuscriptcentral.com/bcb-pubs

Biochemistry and Cell Biology

261x383mm (300 x 300 DPI)

t

af

Dr
https://mc06.manuscriptcentral.com/bcb-pubs

Page 24 of 29

Page 25 of 29

Biochemistry and Cell Biology

t

af

Dr
Fig. 2. Fzd7 expression in undifferentiated, and PrE cells. (A) qRT-PCR results showing the dramatic increase
in Gata6 expression in F9 cells following RA treatment. (B) qRT-PCR analysis of Fzd7 in cells treated with RA
for 4 days, but not 3 days, shows that Fzd7 expression was significantly higher when compared to
undifferentiated (DMSO-treated) F9 cells. Data are representative of three independent experiments.
*denotes significance (p<0.05).
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Fig. 3. Overexpression of Fzd7 was sufficient to activate β-catenin/TCF/LEF-dependent transcription in F9
cells, but not at inducing differentiation. (A) F9 cells were transfected with pcDNA3.1 or Fzd7, or treated
with DMSO or RA and total RNA or protein lysate was collected after 5 days. qRT-PCR analysis with primers
for Fzd7 showed that Fzd7 mRNA was expressed 163-fold higher in Fzd7-transfected cells relative to
pcDNA3.1-transfected cells. (B) F9 cells were co-transfected with pBARL (β-catenin activated reporter
luciferase) and pRL-TK (Renilla luciferase) plasmids, as well as either Fzd7 or pcDNA3.1-empty vector, or
treated with RA or DMSO for 48h. Luciferase activity results showed that cells treated with RA or Fzd7
showed a 4.32 and a 3.06 fold-increase in activity, respectively, relative to DMSO-treated cells
(Supplementary data). (C) Representative blot showing DAB2 signals in RA-treated F9 cells, but not in
DMSO-treated or Fzd7-transfected cells. (D) Densitometric analysis confirmed that DAB2 levels were
significantly different in RA-treated F9 cells, but not in DMSO-treated or Fzd7-transfected cells. (E)
Representative blot showing a TROMA-1 signal in RA-treated, but not in DMSO-treated, Fzd7 or pcDNA3.1transfected cells. Antibodies against β-actin were used to ensure equal loading in all lanes. Data represent
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the mean and standard error of three independent experiments (p<0.05). Luciferase activity was calculated
by normalizing firefly luciferase activity to Renilla activity. For fold changes in TCF/LEF luciferase activity
relative to DMSO, see Supplementary data.
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Fig. 4. siRNA knockdown of Fzd7 had no apparent effect on PrE formation. F9 cells were transfected with
Fzd7 siRNA or non-targeting (NT) control siRNA and treated with RA for 3 days. (A) qRT-PCR analysis
indicated that Fzd7 mRNA expression was significantly reduced relative to levels in non-targeting control
siRNA-transfected cells. (B) Immunoblot analysis showing reduced DAB2 levels in Fzd7 siRNA-transfected
cells when compared to non-targeting control siRNA-transfected cells after treatment with RA. (C)
Densitometric analysis confirmed that DAB2 levels were reduced in Fzd7 siRNA-transfected cells when
compared to non-targeting control siRNA-transfected cells after treatment with RA. (D) Immunoblot results
showed TROMA-1 levels in Fzd7 siRNA-transfected cells were approximately equal to those in the nontargeting control siRNA-transfected cells after treatment with RA, and cells treated with RA alone. (E)
Densitometric analysis confirmed that TROMA-1 levels were not significantly different in RA-treated cells
transfected with Fzd7 siRNA compared to non-targeting control-transfected cells treated with RA. Antibodies
against β-actin were used to ensure equal loading in all lanes. Densitometric data was collected by
comparing the TROMA-1/β-actin ratio in each sample. Data represent the mean and standard error of three
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independent experiments (p<0.05).
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Fig. 5. Dkk1 expression following RA treatment or Wnt6 overexpression. (A) qRT-PCR analysis showed that
the expression of Dkk1 significantly increased at 3 and 4 days after RA treatment compared to DMSOtreated cells or cells treated with RA for 1 day. Expression of Dkk1 at day 2 of RA treatment was not
significantly different compared to DMSO-treated cells or cells treated with RA for 1 or 3 days, but was
significantly different from Dkk1 expression at 4 days post-RA treatment. Analysis also indicated that
compared to DMSO-treated cells, Dkk1 levels were increased by 119 and 611-fold at 3 and 4 days post-RA
treatment, respectively (Supplementary data). Expression of Dkk1 mRNA was normalized to the expression
of L14 mRNA. (B) End point PCR revealed the presence of a Wnt6 amplicon in cells transfected with
pcDNA3.1-Wnt6, but not in those transfected with the empty vector control. (C) Total RNA was also isolated
from F9 cells transfected with pcDNA3.1-Wnt6 and qRT-PCR analysis indicated that Dkk1 mRNA expression
increased by 2.92-fold in Wnt6-transfected cells compared to the empty vector control. Data represent the
mean and standard error of three independent experiments. Letters and * denote significance (p<0.05).
Fold changes in Dkk1 mRNA expression relative to DMSO or empty vector treatments are presented in the
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Supplementary data.
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Fig. 6. F9 cells transfected with Myc-DKK1 show decreased expression of PrE markers following RA
treatment. F9 cells were transfected with pcDNA3.1 or Myc-DKK1 and treated with DMSO or RA, or treated
with DMSO or RA alone. (A) Immunoblot analysis showed a TROMA-1 signal in cells transfected with
pcDNA3.1 and treated with RA and cells treated with RA alone. This signal was also present in cells
transfected with Myc-DKK1 and treated with RA, however, its intensity was reduced in comparison to the
positive controls (RA and pcDNA3.1+RA). β-actin served as a loading control. (B) Densitometric analysis
confirmed that there was a significant reduction in TROMA-1 levels in cells transfected with Myc-DKK1 and
treated with RA, compared to cells transfected with empty vector and treated with RA. (C) Total RNA was
collected from F9 cells transfected with Myc-DKK1 and treated with RA or transfected with empty vector and
treated with DMSO or RA, and qRT-PCR analysis was performed using Dab2 primers. Results showed that
Dab2 expression was significantly reduced (by approximately 23-fold; Supplementary data) in Myc-DKK1
transfected, RA-treated cells compared to empty vector transfected, RA-treated cells. Data represent the
mean and standard error of three independent experiments. * denotes significance (p<0.05).
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Fig.7. MYC-DKK1-conditioned media attenuated RA-induced PrE differentiation. (A) HEK-293 cells were
transfected with pcDNA3.1 or Myc-DKK1 and immunoblot analysis of lysates with the 9E10 antibody showed
the ecoptic DKK1 protein present in cells transfected with Myc-DKK1, but not pcDNA3.1. (B) F9 cells cotreated with the concentrated CM from HEK-293 cells and either DMSO or RA were collected for immunoblot
analysis. A representative blot showing reduced TROMA-1 levels in cells treated with the MYC-DKK1-CM and
RA compared to pcDNA3.1-CM and RA. (C) Densitometry analysis confirmed that there was a significant
decrease in TROMA-1 signal (0.39-fold) in cells co-treated with MYC-DKK1-CM and RA, compared to cells cotreated with pcDNA3.1-CM and RA. Data in (B) and (C) represent three independent experiments.* denotes
significance (p<0.05).
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